Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early MMR booster vaccination in children with juvenile idiopathic arthritis
NL-OMON26319Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- May 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of measles, mumps, and rubella vaccine in juvenile idiopathic arthritis (JIA) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Safety: juvenile idiopathic arthritis disease activity, Safety: vaccine-related infectious adverse effects and 1 more. Started May 2008; status: active, not recruiting.
02
Drugs
measles, mumps, and rubella vaccine
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NL-OMON26319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26319.